Gary Sweet, MD
Surgery · Wausau, WINPI 1023229382
Payments from drug & device makers
What this record shows
This record is dominated by education: $5,500 of the $7,586 with a category attached, or 72.5%. Intuitive Surgical accounts for 96.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $6,896 and has fallen 98.4% since, to $108 in 2025.
Across 26 payments — averaging $291.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Davol Inc.$92
- Olympus America Inc.$59
- KARL Storz Endoscopy-america$30
- Innocoll Pharmaceuticals Limited$29
- Merck$27
- plus $41 from 2 others
What the payments were for
- Travel & lodging$1,43219%
- Food & beverage$6549%
- Education$5,50072%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 15 | $7,308 |
| Davol Inc. | 3 | $92 |
| Olympus America Inc. | 3 | $59 |
| KARL Storz Endoscopy-america | 1 | $30 |
| Innocoll Pharmaceuticals Limited | 1 | $29 |
| Merck | 1 | $27 |
| Medtronic | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$6,926
How this compares
$7,586 in reported general payments places this provider in the 75th percentile of 499 surgery providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 19 | $607 |
| Omeprazole | 37 | $402 |
| Ketorolac Tromethamine | 35 | $318 |
| Tramadol Hcl | 74 | $158 |
| Metronidazole | 22 | $60 |
| Ciprofloxacin Hcl | 18 | $26 |
Paid to pharmacies, not to this prescriber.
Other surgery in Wausau
- Peter UllrichAppleton$18M
- Matthew GoldblattMilwaukee$594K
- Raymond GeorgenNeenah$325K
- Cynthia GeocarisGreen Bay$263K
- Rana HigginsMilwaukee$148K
- Mustafa BadruddujaKenosha$134K
- Geoffrey RoelantEau Claire$118K
- Peter JanuChilton$113K
- Manfred ChiangBrookfield$110K
- Ryan JuzaMadison$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.